Testing effectiveness (Phase 2)Looking for participantsNCT06926595
What this trial is testing
Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention
Who this might be right for
Graft-versus-Host Disease (GVHD)Hematologic MalignanciesAllogeneic Stem Cell Transplantation
Milton S. Hershey Medical Center 41